UBS O'Connor’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.29M | Buy |
+565,000
| New | +$1.29M | 0.07% | 169 |
|
2024
Q2 | – | Sell |
-155,857
| Closed | -$994K | – | 440 |
|
2024
Q1 | $994K | Sell |
155,857
-382,909
| -71% | -$2.44M | 0.03% | 273 |
|
2023
Q4 | $3.47M | Sell |
538,766
-47,153
| -8% | -$304K | 0.11% | 102 |
|
2023
Q3 | $1.37M | Buy |
585,919
+55,000
| +10% | +$128K | 0.02% | 293 |
|
2023
Q2 | $1.26M | Sell |
530,919
-226,089
| -30% | -$538K | 0.03% | 356 |
|
2023
Q1 | $1.39M | Buy |
+757,008
| New | +$1.39M | 0.03% | 372 |
|
2022
Q4 | – | Sell |
-584,406
| Closed | -$1.25M | – | 40 |
|
2022
Q3 | $1.25M | Buy |
584,406
+160
| +0% | +$343 | 0.01% | 710 |
|
2022
Q2 | $1.65M | Buy |
+584,246
| New | +$1.65M | 0.02% | 682 |
|